Erik L. Ridley and Philip Ward[email protected]AIRadNet broadens AI focus with acquisitions of Aidence, QuantibImaging services provider RadNet has acquired Dutch artificial intelligence (AI) software developers Aidence and Quantib in deals that the company hopes will enable wide-scale screening programs for lung and prostate cancer.January 23, 2022Page 1 of 1Top StoriesCTPET/CT identifies bone demineralization in breast cancer patientsPET/CT holds promise as an opportunistic osteoporosis screening tool in high-risk oncology subgroups.MRIIs MRI in patients with retained metal fragments dangerous?Womens ImagingAI shows promise as second reader in breast cancer screeningResidents/FellowsRad residents show interest in global health imaging, but face barriersAIInvestigators test ChatGPT-4 Turbo for radiology AI monitoring